Trump Executive Order Tracker | Akin Public Policy and Lobbying

Ensuring American Pharmaceutical Supply Chain Resilience by Filling the Strategic Active Pharmaceutical Ingredients Reserve (Trump EO Tracker)

August 13, 2025

Reading Time : 2 min
Trump Executive Order Tracker | Akin Public Policy and Lobbying

The Executive Order aims to bolster the resilience of the United States’s pharmaceutical supply chain by stockpiling Active Pharmaceutical Ingredients (“APIs”) for critical medicines in the Strategic Active Pharmaceutical Ingredients Reserve (“SAPIR”) and encouraging the domestic production and procurement of such APIs.

The EO includes several directives and deadlines.

  • Section 2(a): Within 30 days of the EO, the Office of the Assistant Secretary for Preparedness and Response (“ASPR”) within the Department of Health and Human Services must create a list “of approximately 26 drugs that are especially critical to the health and security interests of the Nation (the critical drugs).” The ASPR must also create an accounting of funds available to finance and maintain the SAPIR repository with a 6-month supply of APIs for critical drugs referenced in Section 2(c). The list and accounting must be provided to the Director of the Office of Management and Budget (“OMB”), who will assist with repurposing available funds.
  • Section 2(b): Within 120 days of the EO, and subject to the availability of funds identified in Section 2(a), the ASPR must prepare the existing SAPIR repository to begin receiving and maintaining APIs.
  • Section 2(c): Subject to the availability of funds identified in Section 2(a), the ASPR must secure a 6-month supply of APIs needed to make critical drugs, prioritizing APIs manufactured domestically. APIs must be placed within the SAPIR repository within 30 days after the repository is certified to receive and maintain APIs.
  • Section 3(a): Within 90 days of the EO, the ASPR must update its 2022 list of 86 essential medicines and medical countermeasures and provide it to the Assistant to the President and Homeland Security Advisor (“APHSA”), the Assistant to the President for Economic Policy (“APEP”), and OMB. The update should include a plan to obtain APIs for drugs on the updated essential medicines list from domestic manufacturers, where possible, and to store and maintain a 6-month supply of those APIs.
  • Section 3(b): The plan in Section 3(a) must also include a proposal to open a second SAPIR site within one year of the EO.

Additional Documentation

Share This Insight

Related Content

Trump Executive Order Tracker

The significant number of executive orders published by the Trump Administration cut across dozens of industries and areas of law. This searchable tool breaks down the orders and their impacts on specific industries and with in-depth analysis of specific orders.

Previous Entries

Trump Executive Order Tracker

August 20, 2026

Establishes a new National Space Transportation Policy that expands commercial and government space transportation capabilities, directs development of launch and reentry infrastructure, strengthens the domestic space transportation industrial base, promotes international market access and revokes the 2013 National Space Transportation Policy.

...

Read More

Trump Executive Order Tracker

August 12, 2026

Establishes a federally supervised program within the National Coordination Center authorizing vetted U.S. private-sector companies to conduct cyber surveillance and cyber effects operations against foreign cyber-enabled transnational criminal organizations, subject to Department of Justice and Department of Homeland Security oversight and approval.

...

Read More

Trump Executive Order Tracker

August 10, 2026

This order requires that the United States recognizes Gold Standard Childhood Vaccine Recommendations informed by the three distinct categories of childhood immunization recommendations identified in the scientific assessment: (i) immunizations recommended for all children; (ii) immunizations recommended for certain high-risk groups or populations; (iii) immunizations based on shared clinical decision-making. Within 90 days of the order, the order directs the Secretary of HHS to offer options to administer core childhood vaccines as single vaccines rather than combination products/doses; assess the ideal timing and sequencing of all core childhood vaccines; develop additional alternative adjuvants to aluminum; ensure continuous evaluation of the risk/benefit profiles of all childhood vaccines; and improve vaccine safety monitoring, transparency and research. The order further directs the Attorney General to take appropriate measures to further meritorious legal actions challenging State laws that conflict with States’ constitutional and Federal statutory obligations related to parental authority, religious freedom, disability accommodations and equal protection under the law.

...

Read More

Trump Executive Order Tracker

August 6, 2026

Directs federal agencies not to issue or accept documents recognizing U.S. citizenship for certain persons born in the U.S. when neither parent is a U.S. citizen, including where a parent is an “alien enemy,” foreign government employee (e.g. an ambassador or foreign embassy employee and a national of the country they work for), involved in commercial birthright citizenship or fraud, involved in a commercial transaction with a surrogate parent in the U.S., or where the birth occurs in a U.S. territory or territorial waters where citizenship is not conferred by federal statute. 

...

Read More

© 2026 Akin Gump Strauss Hauer & Feld LLP. All rights reserved. Attorney advertising. This document is distributed for informational use only; it does not constitute legal advice and should not be used as such. Prior results do not guarantee a similar outcome. Akin is the practicing name of Akin Gump LLP, a New York limited liability partnership authorized and regulated by the Solicitors Regulation Authority under number 267321. A list of the partners is available for inspection at Eighth Floor, Ten Bishops Square, London E1 6EG. For more information about Akin Gump LLP, Akin Gump Strauss Hauer & Feld LLP and other associated entities under which the Akin Gump network operates worldwide, please see our Legal Notices page.